The primary objective of this study was to describe in a geographically defined population the incidence of procedures requiring general anesthesia up to the child’s third birthday, and the patient characteristics associated with receiving these procedures. A secondary objective was to determine the proportion of children in the population who meet the risk criteria promulgated by the Food and Drug Administration (FDA).
Recent Posts
- SmartTots and the Power of Scientific Public–Private Partnerships with the US Food and Drug Administration
- Effects of Dexmedetomidine-Remifentanil on Neurodevelopment of Children after Inhalation Anesthesia: A Randomized Clinical Trial
- A Scoping Review of the Mechanisms Underlying Developmental Anesthetic Neurotoxicity
- Anesthesia-induced Developmental Neurotoxicity in Pediatric Population
- Experiencing Anesthesia and Surgery Early in Life Impairs Cognitive and Behavioral Development